newsfilter
← Latest News
PR Newswire·

BioMarin Reports Second Quarter 2026 Financial and Operating Results

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the second quarter ended June 30, 2026. "This quarter, we executed...